Mylan Laboratories Limited

Cases where party is a Patent Asserter

Only "example" cases are shown here, for full list contact Shawn Miller

Cases where party is an Alleged Infringer

Displaying 1 - 50 of 60
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
1 ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al 1:15-cv-01402 N.D.Ill.
  • 8 Product company
AbbVie Inc.
2 ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al 1:15-cv-01402 N.D.Ill.
  • 8 Product company
Abbvie Deutschland GMBH & Co. KG
3 ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al 1:15-cv-01402 N.D.Ill.
  • 8 Product company
Abbvie Deutschland GMBH & Co. KG
4 AbbVie Inc. v. Mylan Pharmaceuticals Inc. et al 1:14-cv-01236 D.Del.
  • 8 Product company
AbbVie Inc.
5 AstraZeneca AB et al v. Mylan Laboratories Limited et al 1:12-cv-00300 D.Del.
  • 8 Product company
Astrazeneca AB
6 AstraZeneca AB et al v. Mylan Laboratories Limited et al 1:12-cv-00300 D.Del.
  • 8 Product company
KBI Inc.
7 AstraZeneca AB et al v. Mylan Laboratories Limited et al 1:12-cv-00300 D.Del.
  • 8 Product company
Astrazeneca LP
8 AstraZeneca AB et al v. Mylan Laboratories Limited et al 1:12-cv-00300 D.Del.
  • 8 Product company
KBI-E Inc.
9 AstraZeneca AB et al v. Mylan Laboratories Limited et al 1:12-cv-00300 D.Del.
  • 8 Product company
Aktiebolaget Hassle
10 ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al 1:15-cv-07009 D.N.J.
  • 8 Product company
Astrazeneca AB
11 ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al 1:15-cv-07009 D.N.J.
  • 8 Product company
Astrazeneca, UK Limited
12 ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al 1:15-cv-07009 D.N.J.
  • 8 Product company
Astrazeneca Pharmaceuticals LP
13 BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al 3:20-cv-02749 D.N.J.
  • 8 Product company
Kaken Pharmaceutical Co. Ltd.
14 BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al 3:20-cv-02749 D.N.J.
  • 8 Product company
Bausch Health US, LLC
15 BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al 3:20-cv-02749 D.N.J.
  • 8 Product company
Bausch Health Ireland Limited
16 BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al 3:20-cv-02749 D.N.J.
  • 8 Product company
Bausch Health Americas, Inc.
17 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim Pharmaceuticals, Inc.
18 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim Corporation
19 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim Pharma GMBH & Co. KG
20 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim International GMBH
21 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:20-cv-00090 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim Pharmaceuticals, Inc.
22 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:20-cv-00090 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim Corporation
23 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:20-cv-00090 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim International GMBH
24 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:20-cv-00090 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim Pharma GMBH & Co. (KG)
25 Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:15-cv-00145 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim Corporation
26 Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:15-cv-00145 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim International GMBH
27 Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:15-cv-00145 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim Pharmaceuticals, Inc.
28 Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al 1:15-cv-00145 N.D.W.Va.
  • 8 Product company
Boehringer Ingelheim Pharma GMBH & Co. KG
29 Cadence Pharmaceuticals Inc. et al v. Agila Specialties Inc. et al 1:14-cv-01499 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
Cadence Pharmaceuticals, Inc.
30 Cadence Pharmaceuticals Inc. et al v. Agila Specialties Inc. et al 1:14-cv-01499 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
Mallinckrodt IP
31 Cadence Pharmaceuticals Inc. et al v. Agila Specialties Inc. et al 1:14-cv-01499 D.Del.
  • 8 Product company
  • 12 IP subsidiary of product company
SCR Pharmatop
32 Fresenius Kabi USA, LLC v. Mylan Laboratories Limited et al 1:14-cv-00205 N.D.W.Va.
  • 8 Product company
Fresenius Kabi USA, LLC
33 GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al 2:16-cv-05828 D.N.J.
  • 8 Product company
  • 6 University/Government/Non-profit
Genzyme Corporation
34 GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al 2:16-cv-05828 D.N.J.
  • 8 Product company
  • 6 University/Government/Non-profit
Southern Research Institute
35 GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al 2:16-cv-05828 D.N.J.
  • 8 Product company
  • 6 University/Government/Non-profit
Sanofi-Aventis U.S. LLC
36 HORIZON PHARMA, INC. et al v. MYLAN PHARMACEUTICALS INC. et al 3:15-cv-03327 D.N.J.
  • 8 Product company
Pozen Inc.
37 HORIZON PHARMA, INC. et al v. MYLAN PHARMACEUTICALS INC. et al 3:15-cv-03327 D.N.J.
  • 8 Product company
Horizon Pharma, Inc.
38 HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. 2:17-cv-11635 D.N.J.
  • 8 Product company
Pozen Inc.
39 HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. 2:17-cv-11635 D.N.J.
  • 8 Product company
Horizon Pharma, Inc.
40 Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC 1:18-cv-00196 D.Del.
  • 8 Product company
Merck Sharp & Dohme Corp.
41 Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC 1:18-cv-00196 D.Del.
  • 8 Product company
Merk Sharp & Dohme Corp.
42 Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al 1:20-md-00445 D.Del.
  • 8 Product company
Novartis Pharmaceuticals Corporation
43 OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. et al 1:14-cv-04508 D.N.J.
  • 8 Product company
Otsuka Pharmaceutical Co., Ltd.
44 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al 2:17-cv-06714 D.N.J.
  • 8 Product company
Progenics Pharmaceuticals Inc
45 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al 2:17-cv-06714 D.N.J.
  • 8 Product company
Salix Pharmaceuticals, Inc.
46 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al 2:17-cv-06714 D.N.J.
  • 8 Product company
Valeant Pharmaceuticals International
47 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al 2:17-cv-06714 D.N.J.
  • 8 Product company
Wyeth LLC
48 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al 2:15-cv-08180 D.N.J.
  • 8 Product company
Valeant Pharmaceuticals International
49 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al 2:15-cv-08180 D.N.J.
  • 8 Product company
Progenics Pharmaceuticals Inc
50 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al 2:15-cv-08180 D.N.J.
  • 8 Product company
Salix Pharmaceuticals, Inc.